Skip to main content

Table 7 Prevalence of infection by different bacterial and fungal species in oral lesions

From: The role of oral microbiota in the development of oral mucositis in pediatric oncology patients treated with antineoplastic drugs: a systematic review

Microbiological evaluation of oral lesions

 

Anirudhan et al. 2008 [29]

Olczak-Kowalczyk et al. 2012 [37]

Bardellini et al. 2017 [30]

70 patients

14 patients

1 patient (case report)

Bacteria

Staphylococcus aureus

4 (14.2%)

1 (7.1%)

 

Coagulase negative Staphylococci

3 (10.7%)

9 (64.2%)

 

Staphylococcus epidermidis

1 (3.6%)

  

Streptococcus viridans

4 (14.2%)

12 (85.7%)

 

Streptococcus bovis

 

2 (14.2%)

 

Streptococcus salivarius

 

1 (7.1%)

 

Group b Streptococcus

1 (3.6%)

  

Leuconostoc spp.

 

1 (7.1%)

 

Enterococcus spp.

1 (3.6%)

1 (7.1%)

 

Neisseria spp.

 

4 (28.5%)

 

Pseudomonas aeruginosa

3 (10.7%)

0

 

Enterobacter cloacae

 

1 (7.1%)

 

Klebsiella oxytoca

 

1 (7.1%)

 

Klebsiella pneumoniae

3 (10.7%)

1 (7.1%)

 

Haemophilus parainfluenzae

 

1 (7.1%)

 

Haemophilus influenzae

   

Prevotella melaninogenica

   

Prevotella disiens

   

Veillonella

3 (10.7%)

  

Peptostreptococcus

1 (3.6%)

  

Lactococcus

1 (3.6%)

  

Raoultella planticola

  

1 (100%)

Fungi

Trichosporon

1 (2.6%)

  

Aspergillus

4 (10.2%)

  

Rhodotorula

1 (2.6%)